Luteolin, a non-selective competitive inhibitor of phosphodiesterases 1–5, displaced [3H]-rolipram from high-affinity rolipram binding sites and reversed xylazine/ketamine-induced anesthesia
Authors:
- 1 February 2010
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 627 (1-3) , 269-275
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Assessment of luteolin (3′,4′,5,7-tetrahydroxyflavone) neuropharmacological activityBehavioural Brain Research, 2008
- Inhibitory effects of quercetin derivatives on phosphodiesterase isozymes and high-affinity [3 H]-rolipram binding in guinea pig tissuesInvestigational New Drugs, 2008
- Evaluation of the Anti-inflammatory Activity of Luteolin in Experimental Animal ModelsPlanta Medica, 2007
- Inhibitor Binding to Type 4 Phosphodiesterase (PDE4) Assessed Using [3H]Piclamilast and [3H]RolipramThe Journal of Pharmacology and Experimental Therapeutics, 2003
- 3-O-Methylquercetin More Selectively Inhibits Phosphodiesterase Subtype 3Planta Medica, 2003
- Assessing the emetic potential of PDE4 inhibitors in ratsBritish Journal of Pharmacology, 2002
- Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenineCellular Signalling, 1995
- Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the NetherlandsJournal of Agricultural and Food Chemistry, 1992
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949